Perigon Wealth Management, LLC Cognition Therapeutics Inc Transaction History

Perigon Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$1.56 - $3.38 $2,340 - $5,070	-1,500 Reduced 0.67%	223,500 $409,000
Q1 2023 May 03, 2023	SELL	$1.51 - $2.3 $1,510 - $2,300	-1,000 Reduced 0.44%	225,000 $445,000
Q4 2022 Feb 14, 2023	BUY	$1.17 - $3.51 $221,247 - $663,741	189,100 Added 512.47%	226,000 $474,000
Q3 2022 Dec 13, 2022	SELL	$1.63 - $3.6 $140,091 - $309,405	-85,946 Reduced 69.96%	36,900 $70,000
Q2 2022 Aug 11, 2022	BUY	$1.5 - $3.45 $184,269 - $423,818	122,846 New	122,846 $259,000
Q3 2011 Nov 14, 2022	SELL	N/A	-85,946	36,900 $70,000

6.58M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $13.2M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.